Thomas Wieringa

Zoekresultaten

• Frontiers in Clinical Diabetes and Healthcare (Tijdschrift)

  Wieringa, T. (Editorial board member)

  mei-2020 → mei-2023

  Activiteit: Editorial work › Academic

• Advisory board member

  Wieringa, T. (Consultant)

  mei-2019

  Activiteit: Consultancy › Academic

• Improved diabetes medication convenience in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: Results of the observational OPTIN-D study

  Wieringa, T. (Speaker)

  20-jan.-2018

  Activiteit: Academic presentation › Academic

• Improved diabetes medication convenience in persons with type 2 diabetes after switching to insulin glargine 300 U/mL (U-300) - The observational OPTIN-D study

  Wieringa, T. (Speaker)

  22-jun.-2018 → 26-jun.-2018

  Activiteit: Academic presentation › Academic

• Training Program for Epidemiologist B

  Wieringa, T. (Other)

  mei-2017 → nov.-2019

  Activiteit: Other research activities › Academic

• An observational study documenting Patient Reported Outcomes (PROs) of people with type 2 diabetes treated with insulin glargine-300 U/mL

  Wieringa, T. (Speaker)

  29-sep.-2017

  Activiteit: Academic presentation › Academic

• Shared decision making in type 2 diabetes care: What is the research agenda?

  Wieringa, T. (Speaker)

  16-apr.-2016

  Activiteit: Academic presentation › Academic

• Does the transition to insulin in persons with type 2 diabetes alter the relationship between hypoglycaemia and quality of life? Secondary analyses of the SPIRIT study

  Wieringa, T. (Speaker)

  23-jan.-2016

  Activiteit: Academic presentation › Academic

• Does the transition to insulin glargine in Dutch persons with type 2 diabetes alter the relationship between hypoglycaemia and quality of life? A prospective observational study

  Wieringa, T. (Speaker)

  26-nov.-2015

  Activiteit: Academic presentation › Academic